B
IMCR icon

Braidwell’s Immunocore IMCR Stock Holding History

Braidwell’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.6M Buy
+521,327
New +$15.4M 0.61% 56
2024
Q3 		– Sell
-797,268
Closed -$27M – 84
2024
Q2 		$27M Buy
+797,268
New +$40.7M 0.85% 42
2024
Q1 		– Sell
-611,365
Closed -$41.8M – 76
2023
Q4 		$41.8M Sell
611,365
-295,608
-33% -$15.4M 1.53% 24
2023
Q3 		$47.1M Buy
906,973
+438,946
+94% +$26M 1.49% 21
2023
Q2 		$28.1M Buy
468,027
+41,917
+10% +$2.39M 0.92% 40
2023
Q1 		$21.1M Buy
+426,110
New +$24M 0.69% 50

Other funds holding IMCR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Braidwell's IMCR Position: Q2 2026 in Review

Braidwell opened a new position in Immunocore (IMCR) in Q2 2026: 521,327 shares worth $16.6M. The stake represents 0.61% of the portfolio and ranks #56 among its holdings. This is a return to the name: Braidwell previously reported a position in IMCR as recently as Q2 2024.

Braidwell first reported a position in IMCR in Q1 2023 and has held it in 6 quarters since. The position peaked at $47.1M in Q3 2023. 136 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.

  • Braidwell held 521,327 shares of Immunocore worth $16.6M as of Q2 2026.
  • Immunocore was a new Braidwell position in Q2 2026.
  • Immunocore made up 0.61% of Braidwell's portfolio in Q2 2026, its #56 holding.
  • Braidwell first reported a position in Immunocore in Q1 2023 and has held it in 6 quarters since.
  • Braidwell's Immunocore position peaked at $47.1M in Q3 2023.
  • 136 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.

Based on Braidwell's 13F filing for Q2 2026, filed 14 Aug 2026.